| 0.2 0 (0%) | 08-19 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.29 |
1-year : | 0.34 |
| Resists | First : | 0.25 |
Second : | 0.29 |
| Pivot price | 0.07 |
|||
| Supports | First : | 0.11 |
Second : | 0.02 |
| MAs | MA(5) : | 0.07 |
MA(20) : | 0.08 |
| MA(100) : | 0.3  |
MA(250) : | 2.85 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 28.2 |
D(3) : | 11.3 |
| RSI | RSI(14): 67 |
|||
| 52-week | High : | 25.59 | Low : | 0.02 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ NEPT ] has closed above the upper band by 28.3%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.25 - 0.25 | 0.25 - 0.25 |
| Low: | 0.2 - 0.2 | 0.2 - 0.2 |
| Close: | 0.2 - 0.2 | 0.2 - 0.2 |
Neptune Wellness Solutions Inc. operates as an integrated health and wellness company in Canada, the United States, and internationally. It builds a portfolio of lifestyle brands and consumer packaged goods products under the Biodroga, Forest Remedies, Ocean Remedies, Neptune Wellness, Mood Ring, PanHash, Sprout, Nosh, MaxSimil, and NurturMe brands. The company also offers turnkey product development and supply chain solutions to business customers in various health and wellness verticals, including nutraceuticals, beauty and personal care products, and organic foods and beverages. In addition, it is involved in the extraction, purification, formulation, and manufacturing of health and wellness products. Further, the company offers Maxsimil, an omega-3 fatty acid delivery technology that uses enzymes that mimic the natural human digestive system to predigest omega-3 fatty acids. It has a collaboration agreement with International Flavors & Fragrances Inc. to co-develop hemp-derived CBD products for the mass retail, and health and wellness markets. The company was incorporated in 1998 and is headquartered in Laval, Canada.
Tue, 30 Apr 2024
Neptune Wellness Solutions insider sells shares worth over $21k - Investing.com
Wed, 06 Mar 2024
Neptune Wellness to be delisted from Nasdaq - Investing.com
Wed, 06 Mar 2024
Neptune Wellness Faces Nasdaq Delisting, Considers OTCQB Move - TipRanks
Mon, 04 Mar 2024
Neptune Announces Michael Cammarata's Resignation Effective February 23, 2024 - Yahoo Finance
Wed, 24 Jan 2024
Neptune Retains Stifel to Explore Strategic Alternatives for Sprout Organics - Yahoo Finance
Tue, 05 Dec 2023
Neptune Wellness shares said to get delisted from Nasdaq (NASDAQ:NEPT) - Seeking Alpha
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 5 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 43.7 (%) |
| Held by Institutions | 6 (%) |
| Shares Short | 25 (K) |
| Shares Short P.Month | 7 (K) |
| EPS | -200.2 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -6.89 |
| Profit Margin | -136.9 % |
| Operating Margin | -232.9 % |
| Return on Assets (ttm) | -67 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -37.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 8.63 |
| EBITDA (p.s.) | -9.97 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -15 (M) |
| Levered Free Cash Flow | -2 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | -0.03 |
| Price to Sales | 0.02 |
| Price to Cash Flow | -0.06 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|